Clinical Trials in Seoul, Songpa-gu
21 recruiting
Showing 1–20 of 20 trials
Recruiting
Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals454 enrolled94 locationsNCT06510374
Recruiting
Phase 3
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Ferring Pharmaceuticals250 enrolled73 locationsNCT06545955
Recruiting
Phase 2
Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines
Chronic Spontaneous Urticaria (CSU)Allergic Diseases
Yuhan Corporation150 enrolled30 locationsNCT07415551
Recruiting
Phase 2
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian CancerEndometrial CancerFallopian Tube Cancer+1 more
Corcept Therapeutics270 enrolled49 locationsNCT06906341
Recruiting
Phase 2
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
Ovarian Cancer
ARCAGY/ GINECO GROUP390 enrolled88 locationsNCT05183984
Recruiting
Phase 2
Pan Tumor Rollover Study
Cancer
Bristol-Myers Squibb1,500 enrolled399 locationsNCT03899155
Recruiting
Phase 4
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
Cerebral InfarctionStenosis Artery
Asan Medical Center2,340 enrolled24 locationsNCT06757764
Recruiting
Not Applicable
Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause
Embolic Stroke of Undetermined Source
Asan Medical Center100 enrolled1 locationNCT07295769
Recruiting
Phase 1Phase 2
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
HER2-positive Advanced Solid Tumor
DualityBio Inc.796 enrolled102 locationsNCT05150691
Recruiting
Not Applicable
Acute Safety and Efficacy of the Pivot Bridge System for Functional Tricuspid Regurgitation
Tricuspid Regurgitation Functional
Tau-MEDICAL Co., Ltd.20 enrolled4 locationsNCT07385625
Recruiting
Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
Coronary Artery Disease
Seung-Jung Park4,000 enrolled15 locationsNCT02792075
Recruiting
Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions
Percutaneous Transluminal Coronary Angioplasty
Seung-Jung Park1,000 enrolled14 locationsNCT02797561
Recruiting
Not Applicable
Left Bundle Branch Versus Minimized Ventricular Pacing in Patients With Sick Sinus Syndrome and Prolonged AV Interval
Sick Sinus SyndromeAtrioventricular Nodal Dysfunction
Asan Medical Center440 enrolled1 locationNCT07314008
Recruiting
Not Applicable
Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease
Coronary Artery DiseaseCoronary Artery Disease (Left Main)
Seung-Jung Park960 enrolled48 locationsNCT05829889
Recruiting
IRIS-Coroflex NEO Cohort
Coronary artery stenosisCoronary Artery Disease
Seung-Jung Park1,000 enrolled11 locationsNCT06177743
Recruiting
Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
Lung Cancer
Se-Hoon Lee800 enrolled3 locationsNCT03578185
Recruiting
Phase 3
Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Disease
Fabry Disease
ISU Abxis Co., Ltd.24 enrolled3 locationsNCT06081062
Recruiting
Phase 4
BPaL(M) Regimen for the Treatment of MDR/RR-TB
Multidrug- and Rifampicin-resistant Tuberculosis
Asan Medical Center80 enrolled1 locationNCT05381194
Recruiting
Phase 3
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
Gastric Cancer
Asan Medical Center870 enrolled1 locationNCT01917552
Recruiting
Phase 1Phase 2
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination
Advanced Solid Tumor
Selecxine420 enrolled9 locationsNCT05525247